The Centers for Medicare & Medicaid Services’ Hospital Price Transparency final rule goes into effect on Jan. 1, 2021. The AHA and three other national organizations sued the federal government challenging the final rule. The case is pending in a federal appeals court.
Mar 5, 2021
A recent report from RAND misses the mark on solutions to the cost of health care and draws its conclusions from the same recycled and incomplete studies.
Dec 21, 2020
AHA letter requesting the Biden Administration exercise enforcement discretion with respect to compliance with the Centers for Medicare…
Dec 11, 2020
AHA letter that outlines initial policy priorities for Biden Administration first 100 days.
Sep 25, 2020
How RAND Corporation is endangering our high-value healthcare systems by oversimplifying the complexities of how the system works.
Sep 22, 2020
The RAND Corporation has released the third edition of its hospital price transparency study. The AHA previously highlighted our extensive concerns with the data and methodology used in the last version.
Jul 29, 2021
The Centers for Medicare & Medicaid Services will host an Aug. 11 webinar on complying with the hospital price transparency rule, which took effect Jan. 1.
Jul 9, 2021
AHA statement on executive order on competition from AHA President and CEO Rick Pollack.
Jul 2, 2021
Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to require the disclosure of drug pricing information in direct-to-consumer (DTC) advertising.